Name: Dimitris Reissis
Theme: Thrombosis
OPTION LIST
|
A |
Tissue Factor |
I |
Warfarin |
|
B |
APTT |
J |
Vitamin K factor concentrates |
|
C |
Nitric Oxide |
K |
Factor V |
|
D |
Low Molecular Weight Heparin (LMWH) |
L |
Lupus Anticoagulant |
|
E |
International Normalised Ratio (INR) |
M |
Unfractionated Heparin |
|
F |
Protein C |
N |
|
|
G |
Factor VIII |
O |
|
|
H |
Antithrombin |
P |
|
For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.
1. Drug used to prevent recurrence of Venous Thromboembolism (VTE) and monitored using INR
2. Drug administered subcutaneously with immediate anticoagulant effect, by potentiating the action of antithrombin
3. Produced by the endothelium and inhibits platelet activation and induces smooth muscle relaxation
4. An excess of this protein causes increased risk of thrombosis
5. A mutated form of this protein is present in 5% of the white population and renders it resistant to protein C
ANSWERS
|
1. I |
2. D |
3. C |
4. G |
5. K |